PREVALENCE OF RENAL DISFUNCTION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA USING FIRST AND SECOND-GENERATION TYROSINE KINASE INHIBITORS
The use of tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia (CML), making it possible for patients to have a life expectancy similar to that of the healthy population. To improve treatment adherence and effectiveness, it is necessary to understand the s...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2023-10-01
|
| シリーズ: | Hematology, Transfusion and Cell Therapy |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2531137923006181 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|